Taken together, our findings suggest that blocking CRHR1-mediated responses inhibit tumor development and growth in an Apcmin/+ background, while inhibiting CRHR2-mediated responses promote tumorigenesis. This evidence concerns the gene CRHR2 and neoplasm.